Biotech · Private company
Healthgen Biotechnology Corp.
Track this companyFree. Adds Healthgen Biotechnology Corp. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- OsrhAAT 1 mg/kg IVPhase 1 · Emphysema Secondary to Congenital AATDClinicalTrials.gov · fetched Nov 12, 2026
- OsrhAAT 10 mg/kg IVPhase 1 · Emphysema Secondary to Congenital AATDClinicalTrials.gov · fetched Nov 12, 2026
- OsrhAAT 20 mg/kg IVPhase 1 · Emphysema Secondary to Congenital AATDClinicalTrials.gov · fetched Nov 12, 2026
- OsrhAAT 3 mg/kg IVPhase 1 · Emphysema Secondary to Congenital AATDClinicalTrials.gov · fetched Nov 12, 2026
- OsrhAAT 40 mg/kg IVPhase 1 · Emphysema Secondary to Congenital AATDClinicalTrials.gov · fetched Nov 12, 2026
- OsrhAAT 60 mg/kg IVPhase 1 · Emphysema Secondary to Congenital AATDClinicalTrials.gov · fetched Nov 12, 2026
- OsrHSA 140 mg/kg IVPhase 1 · Ascites HepaticClinicalTrials.gov · fetched Nov 12, 2026
- OsrHSA 20 mg/kg IVPhase 1 · Ascites HepaticClinicalTrials.gov · fetched Nov 12, 2026
- OsrHSA 200 mg/kg IVPhase 1 · Ascites HepaticClinicalTrials.gov · fetched Nov 12, 2026
- OsrHSA 40 mg/kg IVPhase 1 · Ascites HepaticClinicalTrials.gov · fetched Nov 12, 2026
- OsrHSA 80 mg/kg IVPhase 1 · Ascites HepaticClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of OsrhAAT or Placebo in Healthy VolunteersPHASE1 · UNKNOWN · started Mar 22, 2022ClinicalTrials.gov NCT05315921 · fetched Nov 12, 2026
- A Study of OsrHSA in Adult Healthy Male and Female VolunteersPHASE1 · COMPLETED · started Nov 4, 2019ClinicalTrials.gov NCT04384523 · fetched Nov 12, 2026